CG Oncology, Inc. Increase (Decrease) in Accounts and Other Receivables
CG Oncology, Inc. (CGON) reported Increase (Decrease) in Accounts and Other Receivables of -$219.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2025-08-08
- CG Oncology, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2025-06-30 was $217.00K.
- CG Oncology, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2025-03-31 was -$436.00K.
- CG Oncology, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2024-12-31 was $644.00K.
- CG Oncology, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2024-09-30 was -$45.00K.
- CG Oncology, Inc. increase (decrease) in accounts and other receivables for fiscal 2024 was $689.00K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2025-06-30 | $217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$219.00K 10-Q · filed 2025-08-08 | $425.00K derived: sum of 3 quarters · filed 2025-08-08 | $380.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$436.00K 10-Q · filed 2025-05-13 | $208.00K derived: sum of 2 quarters · filed 2025-05-13 | $163.00K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2024-12-31 | $644.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $599.00K derived: sum of 2 quarters · filed 2025-03-28 | $689.00K 10-K · filed 2025-03-28 | |
| 2024-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $45.00K 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $90.00K 10-Q · filed 2025-08-08 | |||
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |